Using vending machines to provide harm reduction services in communities
Vending machines: a low-barrier method to deliver harm reduction services in the community
['FUNDING_OTHER'] · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · NIH-11054827
This study is looking at how smart vending machines can help people at risk of substance use issues by providing easy access to lifesaving tools like naloxone and fentanyl test strips, all in a friendly and non-judgmental way, to help reduce overdose deaths in the community.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | PENNSYLVANIA STATE UNIV HERSHEY MED CTR (nih funded) |
| Locations | 1 site (HERSHEY, UNITED STATES) |
| Trial ID | NIH-11054827 on ClinicalTrials.gov |
What this research studies
This research investigates the use of smart vending machines to deliver harm reduction services, such as naloxone and fentanyl test strips, to individuals at risk of substance use disorders. By providing these services in a non-stigmatizing and easily accessible manner, the project aims to increase engagement with underserved populations and reduce overdose deaths. The study will evaluate the effectiveness of these vending machines in various community settings and identify barriers to their implementation. It employs a rigorous approach to ensure that the findings can inform future strategies for harm reduction.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk of substance use disorders or those who may benefit from harm reduction services.
Not a fit: Patients who are not at risk of substance use disorders or do not require harm reduction services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce overdose deaths and improve access to treatment for individuals with substance use disorders.
How similar studies have performed: Other research has shown promise in using innovative delivery methods for harm reduction services, suggesting that this approach could be effective.
Where this research is happening
HERSHEY, UNITED STATES
- PENNSYLVANIA STATE UNIV HERSHEY MED CTR — HERSHEY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZHANG, ALICE — PENNSYLVANIA STATE UNIV HERSHEY MED CTR
- Study coordinator: ZHANG, ALICE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus, addictive disorder